Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
Magnetic Resonance in Medicine
|
June 16, 2009
Correlative dynamic contrast MRI and microscopic assessments of tumor vascularity in RIP-Tag2 transgenic mice
Barbara Sennino, Hans-Juergen Raatschen, Michael F Wendland, et al.
Cancer Science
|
October 8, 2024
Population pharmacokinetic model of ABL001/CTX-009 (anti-VEGF/DLL4) in adult cancer patients with solid tumor
Joo Young Na, Juyeun Jeon, Ki Young Huh, et al.
Breast Cancer Research : BCR
|
April 26, 2012
Early vascular deficits are correlated with delayed mammary tumorigenesis in the MMTV-PyMT transgenic mouse following genetic ablation of the NG2 proteoglycan
Krissa Gibby, Weon-Kyoo You, Kuniko Kadoya, et al.
Plos One
|
April 1, 2015
The invadopodia scaffold protein Tks5 is required for the growth of human breast cancer cells in vitro and in vivo
Barbara Blouw, Manishha Patel, Shinji Iizuka, et al.
ACS Synthetic Biology
|
January 19, 2024
Genome-Wide CRISPR/Cas9 Screening Unveils a Novel Target ATF7IP-SETDB1 Complex for Enhancing Difficult-to-Express Protein Production
Su Hyun Kim, Jong-Ho Park, Sungwook Shin, et al.
Mabs
|
April 27, 2021
N-terminal selective conjugation method widens the therapeutic window of antibody-drug conjugates by improving tolerability and stability
Min Ji Ko, Daehae Song, Juhee Kim, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
September 14, 2016
Development, validation, and application of ELISA for detection of anti-HD105 antibodies in pre-clinical safety evaluation using monkeys
Woo Hyuck Choi, Hye Ryun Jo, Eun-Jeong Jeon, et al.
International Journal of Molecular Sciences
|
January 1, 2021
ABL001, a Bispecific Antibody Targeting VEGF and DLL4, with Chemotherapy, Synergistically Inhibits Tumor Progression in Xenograft Models
Dong-Hoon Yeom, Yo-Seob Lee, Ilhwan Ryu, et al.
Mabs
|
April 7, 2016
Simultaneous blockade of VEGF and Dll4 by HD105, a bispecific antibody, inhibits tumor progression and angiogenesis
Dongheon Lee, Dongin Kim, Yu Bin Choi, et al.
Cancer Discovery
|
May 16, 2012
Suppression of tumor invasion and metastasis by concurrent inhibition of c-Met and VEGF signaling in pancreatic neuroendocrine tumors
Barbara Sennino, Toshina Ishiguro-Oonuma, Ying Wei, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
Magnetic Resonance in Medicine
|
June 16, 2009
Correlative dynamic contrast MRI and microscopic assessments of tumor vascularity in RIP-Tag2 transgenic mice
Barbara Sennino, Hans-Juergen Raatschen, Michael F Wendland, et al.
Cancer Science
|
October 8, 2024
Population pharmacokinetic model of ABL001/CTX-009 (anti-VEGF/DLL4) in adult cancer patients with solid tumor
Joo Young Na, Juyeun Jeon, Ki Young Huh, et al.
Breast Cancer Research : BCR
|
April 26, 2012
Early vascular deficits are correlated with delayed mammary tumorigenesis in the MMTV-PyMT transgenic mouse following genetic ablation of the NG2 proteoglycan
Krissa Gibby, Weon-Kyoo You, Kuniko Kadoya, et al.
Plos One
|
April 1, 2015
The invadopodia scaffold protein Tks5 is required for the growth of human breast cancer cells in vitro and in vivo
Barbara Blouw, Manishha Patel, Shinji Iizuka, et al.
ACS Synthetic Biology
|
January 19, 2024
Genome-Wide CRISPR/Cas9 Screening Unveils a Novel Target ATF7IP-SETDB1 Complex for Enhancing Difficult-to-Express Protein Production
Su Hyun Kim, Jong-Ho Park, Sungwook Shin, et al.
Mabs
|
April 27, 2021
N-terminal selective conjugation method widens the therapeutic window of antibody-drug conjugates by improving tolerability and stability
Min Ji Ko, Daehae Song, Juhee Kim, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
September 14, 2016
Development, validation, and application of ELISA for detection of anti-HD105 antibodies in pre-clinical safety evaluation using monkeys
Woo Hyuck Choi, Hye Ryun Jo, Eun-Jeong Jeon, et al.
International Journal of Molecular Sciences
|
January 1, 2021
ABL001, a Bispecific Antibody Targeting VEGF and DLL4, with Chemotherapy, Synergistically Inhibits Tumor Progression in Xenograft Models
Dong-Hoon Yeom, Yo-Seob Lee, Ilhwan Ryu, et al.
Mabs
|
April 7, 2016
Simultaneous blockade of VEGF and Dll4 by HD105, a bispecific antibody, inhibits tumor progression and angiogenesis
Dongheon Lee, Dongin Kim, Yu Bin Choi, et al.
Cancer Discovery
|
May 16, 2012
Suppression of tumor invasion and metastasis by concurrent inhibition of c-Met and VEGF signaling in pancreatic neuroendocrine tumors
Barbara Sennino, Toshina Ishiguro-Oonuma, Ying Wei, et al.
Page
of 4